Did you know?
The Marihuana for Medical Purposes Regulations (MMPR) were published in the Canada Gazette, Part II, on June 19, 2013. These regulations provide a new way to access marihuana for medical purposes and will operate concurrently with the Marihuana Medical Access Regulations (MMAR) until March 31, 2014, when the MMAR will be repealed. The MMAR and MMPR deal exclusively with the medical use of marihuana and do not address the issue of legalizing marihuana for general use.
Dried marihuana is not an approved drug or medicine in Canada. The Government of Canada does not endorse the use of marihuana, but the courts have required reasonable access to a legal source of marihuana when authorized by a physician.
The Marihuana Medical Access Program ends on March 31, 2014. This is also the date that all Authorizations to Possess, Personal-Use Production Licences and Designated-Person Production Licences expire. As of April 1, 2014, the only legal access to marihuana for medical purposes will be through licensed producers under the Marihuana for Medical Purposes Regulations, even if you have an authorization to possess or a licence to produce that has a later date.
Effective October 1, 2013, to comply with recent changes to the Marihuana Medical Access Regulations, Health Canada is no longer accepting the following types of applications:
Health Canada is still accepting renewal and amendment applications that do not include the above-noted changes and applications for new Authorizations to Possess dried marihuana for medical purposes where the source of supply indicated is Health Canada supply.
For new applications, renewals and amendments under the Marihuana Medical Access Program, the standard processing time is up to 10 weeks from the date of receipt of a complete application.
A letter to clients of the Marihuana Medical Access Program and transition information document about these changes can be found here.